Presentation TCT 2013

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

Presenter: Deepak Bhatt

October 30, 2013

REGISTER for free or LOG IN to view this content

The Case for Intravenous Cangrelor as the Preferred ADP Antagonist to Support Primary PCI

ACS/AMI

Presentation

TCT 2013

Up Next

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

More slides +

Presentation TCT 2013

Important Lessons from SIMPLICITY HTN-3 (Inclusion Criteria, Site Selection, and Study Endpoints): What I Would Do Differently Next Time?

Presenter: Deepak Bhatt

October 30, 2013

Presentation TCT 2013

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Presenter: Javier Escaned

October 30, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.